Home › Funds › Farallon Capital Management › BEAM
Farallon Capital Management position in BEAM
BEAM THERAPEUTICS INC · Health Care
Latest position (Q2 2026)10.24M sh
Reported value held$351.31M
Portfolio Weight1.63%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.72M | $149.45M | New |
| Q4 2021 | 2.27M | $180.50M | Add |
| Q1 2022 | 2.59M | $148.66M | Add |
| Q2 2022 | 3.47M | $134.41M | Add |
| Q3 2022 | 3.63M | $172.99M | Add |
| Q4 2022 | 3.40M | $132.97M | Reduce |
| Q1 2023 | 3.43M | $105.09M | Add |
| Q2 2023 | 3.44M | $109.89M | Hold |
| Q3 2023 | 4.48M | $107.79M | Add |
| Q4 2023 | 4.11M | $111.76M | Reduce |
| Q1 2024 | 4.51M | $149.07M | Add |
| Q2 2024 | 7.91M | $185.40M | Add |
| Q3 2024 | 8.21M | $201.10M | Add |
| Q4 2024 | 8.24M | $204.33M | Hold |
| Q1 2025 | 9.93M | $193.90M | Add |
| Q2 2025 | 10.01M | $170.32M | Add |
| Q3 2025 | 10.06M | $244.23M | Hold |
| Q4 2025 | 10.06M | $278.95M | Hold |
| Q1 2026 | 10.13M | $241.51M | Add |
| Q2 2026 | 10.24M | $351.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BEAM
- Fidelity Management & Research (FMR) 12.61M sh · $432.74M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- BlackRock Inc 9.00M sh · $308.80M · Q2 2026
- Vanguard Group 9.19M sh · $254.84M · Q4 2025
- Geode Capital Management 2.60M sh · $89.14M · Q2 2026
- Morgan Stanley 1.95M sh · $66.96M · Q2 2026
- Two Sigma Investments 1.39M sh · $47.64M · Q2 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Goldman Sachs Group 1.31M sh · $44.96M · Q2 2026
- Northern Trust Corp 933.48K sh · $32.04M · Q2 2026
- Charles Schwab Investment Management 885.90K sh · $30.40M · Q2 2026